94 related articles for article (PubMed ID: 1575742)
1. Covalent modification of Alzheimer's amyloid beta-peptide in formic acid solutions.
Orlando R; Kenny PT; Zagorski MG
Biochem Biophys Res Commun; 1992 Apr; 184(2):686-91. PubMed ID: 1575742
[TBL] [Abstract][Full Text] [Related]
2. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.
Barrow CJ; Yasuda A; Kenny PT; Zagorski MG
J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's beta-amyloid protein is covalently modified when dissolved in formic acid.
Klunk WE; Pettegrew JW
J Neurochem; 1990 Jun; 54(6):2050-6. PubMed ID: 2187054
[TBL] [Abstract][Full Text] [Related]
4. NMR identification of the formic acid-modified residue in Alzheimer's amyloid protein.
Klunk WE; Xu CJ; Pettegrew JW
J Neurochem; 1994 Jan; 62(1):349-54. PubMed ID: 8263535
[TBL] [Abstract][Full Text] [Related]
5. Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease.
Shao H; Jao S; Ma K; Zagorski MG
J Mol Biol; 1999 Jan; 285(2):755-73. PubMed ID: 9878442
[TBL] [Abstract][Full Text] [Related]
6. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.
Miller DL; Papayannopoulos IA; Styles J; Bobin SA; Lin YY; Biemann K; Iqbal K
Arch Biochem Biophys; 1993 Feb; 301(1):41-52. PubMed ID: 8442665
[TBL] [Abstract][Full Text] [Related]
7. Formylated peptides from cyanogen bromide digests identified by fast atom bombardment mass spectrometry.
Goodlett DR; Armstrong FB; Creech RJ; van Breemen RB
Anal Biochem; 1990 Apr; 186(1):116-20. PubMed ID: 2356963
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of aggregation of synthetic beta-amyloid peptide.
Tomski SJ; Murphy RM
Arch Biochem Biophys; 1992 May; 294(2):630-8. PubMed ID: 1567217
[TBL] [Abstract][Full Text] [Related]
9. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
Kreutzer AG; Nowick JS
Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
[TBL] [Abstract][Full Text] [Related]
10. Structural Interconversion in Alzheimer's Amyloid-β(16-35) Peptide in an Aqueous Solution.
Alves NA; Frigori RB
J Phys Chem B; 2018 Feb; 122(6):1869-1875. PubMed ID: 29351720
[TBL] [Abstract][Full Text] [Related]
11. Some neurochemical applications of electrospray ionization-mass spectrometry.
Oliver RW; Green BN
Biochem Soc Trans; 1994 Feb; 22(1):131-5. PubMed ID: 8206208
[No Abstract] [Full Text] [Related]
12. Assessment of the aggregation propensity of the β -amyloid peptide during the synthesis and when free in solution.
Malavolta L; Pinto MR; Nakaie CR
Protein Pept Lett; 2013 Aug; 20(8):848-55. PubMed ID: 23458076
[TBL] [Abstract][Full Text] [Related]
13. A biotechnological method provides access to aggregation competent monomeric Alzheimer's 1-42 residue amyloid peptide.
Döbeli H; Draeger N; Huber G; Jakob P; Schmidt D; Seilheimer B; Stüber D; Wipf B; Zulauf M
Biotechnology (N Y); 1995 Sep; 13(9):988-93. PubMed ID: 9636276
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths.
Snyder SW; Ladror US; Wade WS; Wang GT; Barrett LW; Matayoshi ED; Huffaker HJ; Krafft GA; Holzman TF
Biophys J; 1994 Sep; 67(3):1216-28. PubMed ID: 7811936
[TBL] [Abstract][Full Text] [Related]
15. Ab initio model studies of copper binding to peptides containing a His-His sequence: relevance to the beta-amyloid peptide of Alzheimer's disease.
Raffa DF; Gómez-Balderas R; Brunelle P; Rickard GA; Rauk A
J Biol Inorg Chem; 2005 Dec; 10(8):887-902. PubMed ID: 16267663
[TBL] [Abstract][Full Text] [Related]
16. Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4.
Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
Eur J Biochem; 1991 Oct; 201(1):61-9. PubMed ID: 1915378
[TBL] [Abstract][Full Text] [Related]
17. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
[TBL] [Abstract][Full Text] [Related]
18. Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide.
Shen CL; Fitzgerald MC; Murphy RM
Biophys J; 1994 Sep; 67(3):1238-46. PubMed ID: 7811938
[TBL] [Abstract][Full Text] [Related]
19. Metal ion mediated transition from random coil to β-sheet and aggregation of Bri2-23, a natural inhibitor of Aβ aggregation.
Luczkowski M; De Ricco R; Stachura M; Potocki S; Hemmingsen L; Valensin D
Metallomics; 2015 Mar; 7(3):478-90. PubMed ID: 25633876
[TBL] [Abstract][Full Text] [Related]
20. An infrared spectroscopy approach to follow β-sheet formation in peptide amyloid assemblies.
Seo J; Hoffmann W; Warnke S; Huang X; Gewinner S; Schöllkopf W; Bowers MT; von Helden G; Pagel K
Nat Chem; 2017 Jan; 9(1):39-44. PubMed ID: 27995915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
